Biosimilar Newsletter Archive

31. 10.11.18 -- Are Biosimilar Companies Overlooking These Critical Markets?
    10/11/2018
    10/11/18 Biosimilar Development Newsletter
32. 10.10.18 -- How To Rapidly Create Single-Use Biomanufacturing Capacity
    10/10/2018
    10/10/18 Biosimilar Development Newsletter
33. 10.04.18 -- Unpacking Mylan's Biosimilar Partnership Strategies
    10/4/2018

    10/04/18 Biosimilar Development Newsletter

34. 09.27.18 -- Interchangeability: One Nation's Debate
    9/27/2018
    09/27/18 Biosimilar Development Newsletter
35. 09.20.18 -- 4 Revelations From FDA's Part 15 Hearing
    9/20/2018

    09/20/18 Biosimilar Development Newsletter

36. 09.13.18 -- Are Biosimilars Brazil's Waterloo?
    9/13/2018

    09/13/18 Biosimilar Development Newsletter

37. 09.12.18 -- How Automation Accelerates Biosimilar Manufacturing With Flexibility And Efficiency
    9/12/2018
    09/12/18 Biosimilar Development Newsletter
38. 09.06.18 -- The Great Canadian Biosimilar Transition
    9/6/2018

    09/06/18 Biosimilar Development Newsletter

39. 08.30.18 -- Can Biosimilars Conquer The "Emotional Hurdle?"
    8/30/2018

    08/30/18 Biosimilar Development Newsletter

40. 08.23.18 -- Biosimilar Value: The Devil Is In The Details
    8/23/2018

    08/23/18 Biosimilar Development Newsletter